FLOW CYTOMETRIC DETERMINATION OF INTRACELLULAR CALCIUM CHANGES IN HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS DURING CONJUGATION TO TUMOR-CELL LINES

被引:5
作者
BROOKS, B
ROBINSON, JH
WINDEBANK, KP
机构
[1] MED SCH NEWCASTLE UPON TYNE, SCH MED, DEPT IMMUNOL, NEWCASTLE UPON TYNE NE2 4HH, TYNE & WEAR, ENGLAND
[2] MED SCH NEWCASTLE UPON TYNE, SCH MED, DEPT CHILD HLTH, NEWCASTLE UPON TYNE NE2 4HH, TYNE & WEAR, ENGLAND
关键词
FLOW CYTOMETRY; CYTOTOXICITY; LYMPHOCYTE; CONJUGATION; CALCIUM;
D O I
10.1016/0022-1759(94)00260-4
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Using a flow cytometric assay, conjugate formation between human peripheral blood mononuclear cells (PBMC) and three different human tumour cell lines has been analysed. Changes in the intracellular calcium levels of PBMC were monitored using the calcium sensitive dye Fluo-3. Target cell populations were distinguished by forward scatter or following loading with the fluorescent dye, SNARF-1. Intracellular calcium was expressed as a ratio of fluorescence of conjugated to unconjugated PBMC and followed for ten minutes after initiation of conjugation. The results demonstrate an apparent increase in intracellular calcium in PBMC conjugated to the NK-sensitive cell line K562, and that the kinetics and magnitude of this response varied considerably between individuals. Tumour cells which were resistant to lysis (as determined in a 4 h chromium release assay) were also capable of eliciting a calcium response from PBMC. Although the induction of a rise in intracellular calcium was therefore not correlated with cytotoxicity, it was greater in IL-2-activated PBMC upon exposure to the same target cell lines as PBMC.
引用
收藏
页码:229 / 239
页数:11
相关论文
共 39 条
[1]  
BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
[2]  
BROOKS B, 1988, CLIN EXP IMMUNOL, V74, P162
[3]  
BROOKS B, 1990, CLIN EXP IMMUNOL, V82, P583
[4]  
BROOKS B, 1992, IMMUNOLOGY, V75, P343
[5]   DISSOCIATION OF NATURAL-KILLER AND LYMPHOCYTE-ACTIVATED KILLER-CELL LYTIC ACTIVITIES IN HUMAN CD3- LARGE GRANULAR LYMPHOCYTES [J].
CLEMENT, MV ;
LEGROSMAIDA, S ;
SOULIE, A ;
GUILLET, J ;
SASPORTES, M .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (03) :697-701
[6]  
DAMLE NK, 1986, J IMMUNOL, V137, P2814
[7]  
EDWARDS BS, 1989, J IMMUNOL, V143, P1058
[8]  
EDWARDS BS, 1993, J IMMUNOL, V150, P4766
[9]  
EDWARDS BS, 1991, SIGNALLING SECRETORY, P77
[10]  
EPSTEIN MA, 1966, J NATL CANCER I, V37, P547